Department of Clinical Laboratory, Suizhou Hospital, Hubei University of Medicine, Suizhou, China.
School of Basic Medical Sciences, Hubei University of Medicine, Suizhou, China.
Bioengineered. 2022 Mar;13(3):4757-4772. doi: 10.1080/21655979.2022.2031673.
Circular RNA circ_0000285 is differentially expressed in several malignancies; however, its role in gliomas is under investigation. Reverse transcription quantitative polymerase chain reaction was conducted to evaluate the expression of circ_0000285, miR-197-3p, and CDC28 protein kinase regulatory subunit 1B (CKS1B) in glioma tissues and cells. Cell Counting Kit-8 and Transwell invasion assays coupled with Western blotting analysis using anti-Bax and anti-Bcl-2 antibodies were performed to evaluate cell proliferation, invasion, and apoptosis. Luciferase reporter and AGO2 RNA immunoprecipitation assays were conducted to verify the interaction between miR-197-3p and circ_0000285 or CKS1B. Xenograft tumor growth was evaluated in mice. We noted that circ_0000285 was highly expressed in glioma tissues and cells and that circ_0000285-silencing retarded tumor growth both in vitro and in vivo. This effect was mediated by the binding of circ_0000285 to miR-197-3p, which silenced CKS1B, an essential driver of glioma cell proliferation and invasion. Thus, circ_0000285 boosted glioma progression by regulating the miR-197-3p/CKS1B axis, highlighting a novel competing endogenous RNA circuit of glioma progression.
环状 RNA circ_0000285 在多种恶性肿瘤中表达差异,但在神经胶质瘤中的作用仍在研究中。采用逆转录定量聚合酶链反应检测神经胶质瘤组织和细胞中 circ_0000285、miR-197-3p 和细胞分裂周期蛋白 28 蛋白激酶调节亚基 1B(CKS1B)的表达。通过细胞计数试剂盒-8 和 Transwell 侵袭实验以及抗 Bax 和抗 Bcl-2 抗体的 Western blot 分析评估细胞增殖、侵袭和凋亡。采用荧光素酶报告和 AGO2 RNA 免疫沉淀实验验证 miR-197-3p 与 circ_0000285 或 CKS1B 的相互作用。在小鼠中评估异种移植肿瘤生长。结果表明,circ_0000285 在神经胶质瘤组织和细胞中高表达,circ_0000285 沉默可在体外和体内均抑制肿瘤生长。这种作用是由 circ_0000285 与 miR-197-3p 结合介导的,后者沉默了 CKS1B,而 CKS1B 是神经胶质瘤细胞增殖和侵袭的关键驱动因子。因此,circ_0000285 通过调节 miR-197-3p/CKS1B 轴促进神经胶质瘤进展,强调了神经胶质瘤进展的新型竞争性内源 RNA 电路。